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There is emerging evidence suggesting that Alzheimer’s disease is a vascular
disorder, caused by impaired cerebral perfusion, which may be promoted
by cardiovascular risk factors that are strongly influenced by lifestyle.
In order to develop an understanding of the exact nature of such a hypothesis,
a biomechanical understanding of the influence of lifestyle factors is pursued.
An extended poroelastic model of perfused parenchymal tissue coupled with
separate workflows concerning subject-specific meshes, permeability tensor
maps and cerebral blood flow variability is used. The subject-specific datasets
used in the modelling of this paper were collected as part of prospective data
collection. Two cases were simulated involving male, non-smokers (control
and mild cognitive impairment (MCI) case) during two states of activity
(high and low). Results showed a marginally reduced clearance of cerebro-
spinal fluid (CSF)/interstitial fluid (ISF), elevated parenchymal tissue
displacement and CSF/ISF accumulation and drainage in the MCI case. The
peak perfusion remained at 8 mm s21 between the two cases.1. Introduction
1.1. Dementia, mild cognitive impairment and Alzheimer’s disease
Alzheimer’s disease (AD) is the most common form of dementia, a clinical syn-
drome of progressive deterioration of cognitive abilities and ordinary daily
functioning [1]. Microscopically, it is characterized by the excessive accumulation
of neurotoxic amyloid-b (Ab) into parenchymal senile plaques orwithin thewalls
of arteries and capillaries in addition to the aggregation of hyperphosphorylated t
into intracellular neurofibrillary tangles and neuropil threads [2,3]. Macroscopic
pathological alterations include atrophy, ventriculomegaly, cortical thinning
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present itself as mild cognitive impairment (MCI), an inter-
mediate state between normal ageing and dementia [5,6]. It
affects 19% of people aged over 65 [7]. It is estimated that
46% of people with MCI develop dementia within 3 years,
compared with 3% of the age-matched population [8].
Modelling transport of fluid within the brain, in a person-
alized manner and from first principles, is essential in order
to help decipher some of the underlying mechanisms that
are currently being investigated with regard to AD. The amy-
loid hypothesis has long been the main driver in trying to
unravel the root causes of this disease. It has been criticized
for its lack in coherent evidence, in addition to its failure in
providing effective treatment regimens [9,10]. An important
question that must be answered relates to whether the
Ab cascade hypothesis is the underlying cause of AD [10].
While Ab is a key molecule in AD, there is evidence to
suggest (along with genetic risk factors [11]) that AD may
be a vascular disorder [12,13], caused by impaired cerebral
perfusion [9,13], which is detectable even in its early
prodromal MCI stage [10,14,15]. The causes of chronic hypo-
perfusion may be varied (e.g. [16]), but there is evidence that
it might be promoted by cardiovascular risk factors [17],
which in turn are strongly influenced by lifestyle [18]. Model-
ling perfused parenchymal tissue may enhance our
understanding of the influence of modifiable lifestyle factors
(LFs) such as smoking, dietary habits and leisure activities
[19] in addition to environmental risk factors (such as sleep
impairment, diabetes and hypertension) [2] in AD chronic
hypoperfusion. This conceptual understanding is expected to
provide novel biomarkers, especially in the early stages of AD.
1.2. Multiple-network poroelastic theory
The classical form of Biot’s consolidation theory [20,21] is
described for an isotropic and nearly incompressible solid
matrix and homogeneous porous medium. The formula-
tion comprises three components: a mechanical equilibrium
equation governing elastic deformation; Darcy’s law for mod-
elling fluid flow; and a mass conservation expression. In the
cerebral environment, the classical Biot’s theory has been
extended to a multiple-network poroelastic theory (MPET)
formulation [22].
1.3. Outline of the article
This paper introduces a novel consolidated pipeline that
integrates three important components: a three-dimensional
(3D) MPET-based model of cerebral parenchyma; an accurate,
fully automated image-based model personalization work-
flow; and a subject-specific boundary condition model. This
pipeline is expected to provide a template in obtaining novel
biomarkers during the early stages of AD. The essential break-
down of the methodology behind the full implementation
scheme will follow in §2, which highlights the integrated
nature of the consolidated pipeline embedded within the
VPH-DARE@IT research platform, and the prospective data
collection programme used to extract the subject-specific data
used in this study. This section is accompanied by mesh inde-
pendence studies. In §3, four MPET simulations are presented,
based on one control and one MCI subject, each during high
and low activity states. The results are discussed in §4, along
with limitations and perspectives for future work. The
conclusions to the paper are given in §5.2. Methodology
2.1. Cross-sectional case–control study of cerebral
blood flow variability
The subject-specific datasets used in the modelling of this paper
were collected as part of the VPH-DARE@IT project (www.vph-
dare.eu), and prospective data collection was conducted at
the Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)
San Camillo, Lido di Venezia, Italy (hereafter referred to as the
‘Lido study’). The Lido study, including a total of 103 people
(50 cognitively healthy controls, age 71.1+ 7.9 years, and 53
with diagnosed MCI, age 75.1+6.7 years), was approved by
the joint ethics committee of the Health Authority Venice 12
and the IRCCS San Camillo (Protocol number 2014.08), and all
participants gave informed consent prior to participation in
the study.
For each subject, several measurement modalities were col-
lected: lifestyle questionnaires and neuropsychological tests,
whole-brain magnetic resonance (MR) imaging, clinical ultra-
sound flow imaging, portable Holter recordings of blood
pressure and actigraph measured activity levels, among others.
Lifestyle information was collected by means of established ques-
tionnaires (CAIDE study [23]). Clinical ultrasound imaging
comprised both carotid ultrasound and cardiac echography (Sie-
mens Acuson X300PE and SC2000, Siemens Healthineers,
Erlangen, Germany). Portable Holter devices (Cardioline
walk200b, Cardioline S.p.A., Milan, Italy) measured both blood
pressure and the electrocardiogram. Physical activity and sleep
were measured using wrist-portable actigraph devices (Motion-
Watch 8, CamNtech Ltd, Cambridge, UK). For the Lido study
cohort, T1-weighted (T1w) and diffusion-weighted MR images
were processed to create accurate 3D whole-brain meshes and
permeability tensor maps (PTMs) of the parenchyma using the
workflow described in §§2.3.1 and 2.3.2; and Holter recordings
and ultrasound flow measurements were used to generate
boundary conditions (BCs) of arterial blood flow using the
models described in §2.3.3.
In this preliminary study, two cases were analysed, one male
control (66 years of age) and one male MCI case (78 years of age).
Information relating to weight, smoking, daily leisure time and
length of sleep was recorded. Both cases were non-smokers.
The daily leisure time ranged from less than 15 min per day (con-
trol) to greater than 1 h (MCI case). The length of sleep was
unavailable for the control subject, whereas for the MCI case,
the recorded time was approximately 6 h.2.2. Three-dimensional multi-poroelastic model
for the cerebral environment
In this paper, the MPET (or multi-poroelastic) model was used to
conduct mechanistic modelling of fluid transport through
the brain parenchyma. Biologically, in a porous medium
representing the cerebral environment, the solid matrix rep-
resents brain parenchyma, and the communicating fluid phases
taken into account are: an arterial network (a), an arteriole/
capillary network (c), a cerebrospinal fluid (CSF)/interstitial
fluid (ISF) network (e) and a venous network (v) (figure 1).
This model allows for the simultaneous solutions of continuity
and momentum conservation equations, in four interconnec-
ted fluid compartments, within a deformable solid matrix
(parenchymal tissue).2.2.1. Governing equations
The MPET model uses the parenchymal tissue displacement (u),
and the pore pressures of the four fluid compartments ( pa, pc,
pe, pv) as the primitive variables in the governing equations,
parenchymal tissue
arterial
blood
(a) (c) (e)
arteriole/
capillary
blood
CSF/ISF
venous blood
(v)
Qin
Qout
Sac Sev
Scv
Sce
Figure 1. The four-compartment MPET model. Flow is prohibited between
the CSF and the arterial network, while directional transfer exists between
(a) and (c), (c) and (v), (c) and (e) and finally (e) and (v). (Online version
in colour.)
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Gr2uþ ðGþ lÞr1 ¼ aarpa þ acrpc þ aerpe þ avrpv, ð2:1Þ
Sa
@pa
@t
þ aa @1
@t
¼ ka
ma
r2pa þ s^c!a, ð2:2Þ
Sc
@pc
@t
þ ac @1
@t
¼ kc
mc
r2pc þ ð^sa!c þ s^e!c þ s^v!cÞ, ð2:3Þ
Se
@pe
@t
þ ae @1
@t
¼ ke
me
r2pe þ ð^sc!e þ s^v!eÞ ð2:4Þ
and Sv
@pv
@t
þ av @1
@t
¼ kv
mv
r2pv þ ð^sc!v þ s^e!vÞ: ð2:5Þ
Equation (2.1) is the equilibrium equation, which describes
the momentum balance in the porous medium. Here, u is the dis-
placement vector; pi the scalar pore pressure in each fluid
compartment (i ¼ a, c, e and v); G the shear modulus; l the
Lame´’s constant; 1 the dilatational strain; ai the Biot–Willis coef-
ficient for each fluid compartment which satisfies f  aa þ ac þ
ae þ av  1 [24,25], where f is the total porosity.
Equations (2.2)–(2.5) are continuity equations, which
describe the mass balance. Here, Si is the specific storage (a
measure of the released fluid volume per unit pressure in the
control volume at constant strain for each fluid compartment);
ki is the permeability tensor for each of the four fluid compart-
ments, which reduces to ki ¼ kiI, with ki a constant and I the
unit tensor, for an isotropic medium; and mi is the viscosity of
each fluid compartment. The sˆ terms in equation (2.2)–(2.5)
define spatially varying source ð^sij . 0Þ or sink ð^sij , 0Þ densities
(rate of fluid transfer between networks) [22,26,27].2.2.2. Boundary conditions and poroelastic constants
In this paper, the volumetric domain that represents the parench-
ymal tissue is bounded by two surfaces, the outer boundary is
the cortical surface and the inner boundary is the ventricular
wall (figure 2). Both surfaces are closed, and the space enclosed
by the ventricular wall lies within the cortical domain. The volu-
metric domain used in modelling is the space between these two
surfaces. The BCs for both the solid and fluid phases are listed
in table 1.
The skull is assumed rigid (adult cases). For simplicity, this
rigid BC is applied directly to the cortical surface, which assumes
no displacement is allowed at this boundary (equation (2.6)). There
are no displacement constraints at the ventricular wall, so it can
expand or contract freely. For continuity of stresses, the pressure
exerted by the CSF within the ventricles on the inner ependymal
surface must balance the poroelastic stress in the parenchymal
tissue [22,26–28]. A subject-specific blood flow profile is used as
the BC for the arterial network at the cortical surface (see §2.3.3).
Descriptions for equations (2.7)–(2.13) can be found in previous
studies [22,26]. Table 2 gives the list of parameters used in the
MPET modelling framework. The majority of the parameters in
this table have been used in previous studies [22,26–31]. It
should be noted that the permeability of the CSF/ISF compart-
ment, ke, listed in table 2 is the base permeability, which ismultiplied by the dimensionless permeability tensor (see §2.3.2)
to calculate the actual permeability for the CSF/ISF compartment
in the subject-specific modelling.
2.2.3. Mesh independence test of multi-poroelastic brain
modelling
The highly coupled governing equations of the MPET have been
discretized using the finite-element method and implemented
into an in-house numerical code, which has been verified [32]
against Terzaghi’s [33] and Mandel’s [34] problems. Here, the
mesh dependence of the 3D MPET simulations using a realistic
brain geometry was investigated, which provided guidance on
mesh resolution in the subject-specific modelling. This geometry
has similar complexity, e.g. the details of the ventricles, sulci and
gyri, etc., as the ones used in the subject-specific modelling.
Twelve meshes were created from the same brain geometry,
with total element numbers ranging from approximately
100 000 to approximately 9 million (figure 3).
In this study, all the simulations used the same set of par-
ameters and BCs. The differences in the numerical solutions are
caused purely by the varying mesh sizes. In the MPET model,
the primitive variables are displacement and the scalar pore press-
ures of the four fluid compartments. Additional variables of
practical interest, such as Darcy velocity and increment of fluid
content [28], are derived from these primitive variables. The con-
vergence of displacement magnitudes, pore pressures and Darcy
velocities are shown in figure 4 (mean values in the entire parench-
ymal domain). It can be seen that all the variables are converging
as the number of tetrahedral elements increases.
In addition, three points were selected in the domain to show
the local convergence behaviour at different representative
positions, i.e. the white matter, the cortical surface and the ventri-
cular wall (figure 5). The variables that are relevant to §4 of this
paper, i.e. the parenchymal tissue displacement, the pore pressure
of the CSF/ISF compartment, the Darcy velocities of the arteriole/
capillary and the CSF/ISF compartments, are plotted against
element number (table 3). It should be noted that for some vari-
ables, due to the application of Dirichlet BCs, the values at these
boundaries remain constant with refined element sizes (not
plotted). In §4, the pore pressure of the CSF/ISF compartment is
referred to as the intracranial pressure (ICP), and the Darcy vel-
ocities of the arteriole/capillary and the CSF/ISF compartments
are used to represent blood perfusion and CSF/ISF clearance. It
can be seen from table 3 that these variables converge as the
element number increases in three positions in the brain. Therefore,
together with the results from figure 4, it is reasonable to suggest
that for this level of brain geometry complexity, 2 million tetrahe-
dral elements are sufficient to give convergent solutions. This
criterion is satisfied in the subject-specific modelling, where the
meshes have 2–3 million elements.
2.3. Subject-specific brain modelling pipeline
The MPET system gives rise to a generic model that simulates bio-
mechanical behaviour of perfused tissue. The models presented
here are personalized for individual subjects on three levels: cer-
ebral geometries, and corresponding computational meshes,
were extracted from structural MR images; spatial maps of CSF/
ISF compartment permeability tensors were estimated from diffu-
sion MR data; and arterial blood flow waveforms, used as cortical
surface BCs, were derived from measurements of blood pressure,
flow velocity and other inputs as described in §2.3.3. The consoli-
dated pipeline (and its outputs) is depicted in figure 6, and its
details will be described in the following three sections. It was
implemented on the MULTIX platform, developed within the
VPH-DARE@IT project. The latter provides a software infrastruc-
ture for integration and harmonization of disparate data inputs
from multiple collections, and for orchestrating large-scale
Figure 2. The two boundary surfaces used to define the volume of the parenchymal tissue. The outer surface (yellow) represents the cortical surface and the inner
surface (turquoise) represents the ventricular wall. (Online version in colour.)
Table 1. BCs used in the MPET modelling.
cortical surface ventricular wall
displacement u ¼ 0 (2.6) no displacement constraints
arterial blood subject-speciﬁc blood ﬂow rpan ¼ 0 (2.7)
arteriole/capillary blood rpcn ¼ 0 (2.8) kc!ventrpcn ¼ Qp (2.9)
CSF/ISF pe ¼ pv þ meRQ0 (2.10)
Qp¼ pd
4
128meL
ðpepskulle Þ
 4pkeðr1 þ un1Þrpenþ 4pðr1 þ un1Þ2 _u
(2.11)
venous blood pv ¼ pbp (2.12) rpvn ¼ 0 (2.13)
Table 2. Parameters used in the MPET modelling.
parameters values units parameters values units
aa,c 0.25 ka,c,e,v 1.0  10210 m2
ae 0.49 vac 1.5  10219 m2 N21s21
av 0.01 vcv 1.5  10219 m2 N21s21
l 505 Pa vev 1.0  10213 m2 N21s21
G 216 Pa vce 1.0  10220 m2 N21s21
L 70  1023 m R 8.5  1013 m23
d 3  1023 m Qp 5.8  1029 m3s21
pbp 650 Pa
Sa,c 2.9  1024 m2 N21
Se 3.9  1024 m2 N21
Sv 1.5  1025 m2 N21
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It correspondingly streamlines the deployment of complex compu-
tational tool-chains, as described here, on data from large cohorts
of subjects.2.3.1. Image-based construction of brain geometries and meshes
In the case of MPET modelling, two main components are needed
from brain models: firstly, an accurate representation of the brain
anatomy, with clear distinctions between cerebral and cerebellar
hemispheres, as well as the ventricular system; secondly, the per-
meability at different regions of the brain tissue (see §2.3.2).
A fully automated workflow (figure 7) has been developed to pro-
vide subject-specific meshes and PTMs for the MPET modelling.The implementation of this workflow used several algorithms,
including both publicly available sources in addition to newly
developed ones. The references for the tools used in this workflow
can be found in [35] (TORTOISE), [36] (NiftyReg) and [37] (ISO2-
Mesh). The first step of this workflow is image segmentation,
which features detailed subcortical (including the ventricular
system) and whole-brain segmentation of T1w-MR images. Fully
automatic segmentation of T1w-MR images was performed, and
unique labels were retained only for the regions of interest for per-
sonalized mesh generation. Labels extracted from the generated
segmentations, incorporating additional features such as separ-
ation of the cerebral hemispheres and the cerebroventricular
system, are shown in figure 8. Sharp features, irregular surface geo-
metries and disconnected island-like artefacts are addressed by
104 075 210 358 653 286 894 274 1 870 381 2 611 119
3 632 392 4 865 468 5 809 007 6 628 419 7 644 856 8 688 950
Figure 3. Twelve meshes with varying element numbers, discretized from the same cerebral geometry. The number of tetrahedral elements is indicated in each
case. (Online version in colour.)
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Figure 4. (a– i) Mean values of displacement magnitudes, pore pressures and Darcy velocities of the four fluid compartments in the parenchymal domain. These
mean values are plotted against the number of tetrahedral elements (order of 106).
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ance, for the purpose of the MPET simulations, is struck between
elimination of artefacts and retention of surface features. Following
image segmentation, the next step is volumetric mesh generation.
The workflow is able to create tetrahedral meshes of sufficient
quality, which consequently preserves structural detail. Figure 10
portrays a uniform element size and distribution within brain par-
enchyma, and a highermesh density in regions close to the cortical
surface and the ventricular wall.2.3.2. Image-based modelling of cerebrospinal fluid/interstitial
fluid compartment permeability
The other important component from the output of this workflow
(figure 7) is subject-specific PTMs. The estimated diffusion tensor
(DT) field and its associated principal eigenvectors were used
to estimate PTMs. The intermediate and final results from proces-
sing diffusion-weighted imaging (DWI) using TORTOISE [35] are
summarized in figure 11. The permeability map gives one
cortical
surface
ventricular
wall
white matter
Figure 5. Selected positions in the parenchymal tissue domain to check local
convergence behaviour with gradually refined meshes. (Online version in
colour.)
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entire brain, a heterogeneous and anisotropic permeability field
has been captured. Figure 11 also shows the permeability map in
terms of principal eigenvalues, which are plotted element-wise
in three mesh cross sections. This PTM was used for the CSF/ISF
compartment in the 3D MPET modelling.
2.3.3. Boundary conditions for arterial blood flow
The remaining component of the subject-specific modelling
pipeline is the personalized BCs for arterial blood flow.
A subject-specific characterization of 24 h blood flow variability
is obtained through a combination of ambulatory blood pressure
measurements, clinical ultrasound flow measurements and math-
ematical modelling [38]. A lumped parameter circulation model
(LPCM) [39] is used to simulate continuous arterial blood flow
and translate spot measurements collected at 15 min intervals to
continuous waveforms of arterial blood flow. Collected data are
then used for model personalization, either as direct inputs
(heart rate) or for optimizing the model parameters. In the latter
case, measured quantities (systolic/diastolic blood pressure, left
ventricle ejection fraction and end-diastolic volume) are used as
a reference, and the model parameters are tuned with the goal of
achieving the best possible fit of the experimental data. Once the
arterial flow waveforms in the internal carotid artery (ICA) are
obtained from the LPCM, they are coupled with another lumped
parameter model for cerebral flow autoregulation [40]. The final
output of this model is a 24 h prediction of middle cerebral
artery flow, where a minimum baseline flow into the brain is pre-
served by a simple two-element feedback control model. Finally,
these continuous waveforms are fed into the MPET modelling as
BCs for the arterial compartment at the cortical surface.
For each subject, four waveformswere calculated at every time
point,which are the ICAblood to the left and right cerebrum (ICAL
and ICAR), and the vertebral artery (VA) blood to the left and right
cerebellum (VAL and VAR). In order to apply these subject-specific
waveforms as BCs for the arterial compartment, the cortical sur-
face is divided into four perfusion regions corresponding to the
four waveforms (figure 12a). The region labels are propagated
through the segmentation tool. In the 3DMPETmodel, the surface
area of each region is calculated in the pre-processing. The total
amount of arterial blood flow is distributed across each perfusion
region and applied as a flow BC to the MPETmodel. This is a sim-
plification of the true cerebral arterial perfusion network ofanterior/middle/posterior cerebral arteries extending along the
pial surface before dividing into smaller penetrating arteries and
arterioles that perfuse the cerebral cortex and deep white matter.
The subject-specific BCs of arterial blood flow were recorded
every 15 min during the day and every 30 min during the night.
Here, two specific measurements were chosen from the 24 h
recording as indicative of the subject’s activity—the first one is
high activity (e.g. exercise) identified by the highest peak values
of arterial blood flow within 24 h; and the second one is low
activity (e.g. sleep) identified by the lowest peak values. Thewave-
forms corresponding to these two activity states were used in the
subject-specific modelling of this paper as BCs for the arterial
compartment (figure 12b–e).3. Results
Figure 12 depicts subject (and activity) specific profiles of ICA
and VA flow in both left and right sides of the cerebrum and
cerebellum. The arterial feeding territories are the left/right
cerebrum (using the ICAL/R profiles) and the left/right cerebel-
lum (using the VAL/R profiles). Figure 12b,c shows the profiles
corresponding to a period of high and low activity for the
control subject. Figure 12d,e shows the same profiles corre-
sponding to a period of high and low activity for the MCI
case. The peak flow rate is extracted from each of these
curves, and the results are listed in table 4. The left ICA pos-
sesses higher flow rates for the control case during both high
and low activity. For the MCI case, the flow rate is higher in
the right ICA during high and low activity.
Table 5 shows the results associated with the difference
between maximum and minimum arterial blood pressure
(DABP) and ICP (DICP) values in the left (L) and right (R)
hemispheres. Both control andMCI results showed a reduction
in DABP and DICP between the two activity states. The control
case exhibited a reduction of under 1 mmHg in DABP for both
hemispheres, while the MCI case showed signs of asymmetric
reduction in DABP, with values of approximately 1.6 and
1.4 mmHg for left and right hemispheres, respectively. As for
the DICP, the control and MCI cases exhibited a reduction of
approximately 0.5 and 0.4 mmHg between high and low
activity states.
Figure 13 depicts four solution fields arising from the
MPET solver, namely clearance (Darcy velocity of CSF/ISF
compartment), blood perfusion (Darcy velocity of capillary
compartment), parenchymal tissue displacement and CSF/
ISF accumulation (positive values of fluid content, ze, of the
CSF/ISF compartment). Comparing the results between the
control and MCI case, it can be seen that parenchymal tissue
displacement and CSF/ISF drainage (ze, 0) are more pro-
nounced. Blood perfusion between the two cases remains at
roughly similar levels, peaking at 8.0 mm s21. The peak clear-
ance in the MCI case is marginally smaller, at 2.4 cm s21 in the
vicinity of the lateral ventricle. For the simulations relating to
low activity, the two sets of results (control and MCI) for the
variables of interest are: peak clearance (1.6 and 1.7 cm s21),
peak perfusion (7.3 and 6.6 mm s21), peak tissue displacement
(7.4 and 8.2 mm), peak CSF/ISF accumulation (2.9 for both
cases) and finally CSF/ISF drainage (22.3 and 24.7).
Figure 14a–c gives a detailed representation of the inter-
linked nature of microstructural organization (white matter)
within the parenchyma (principal eigenvalue map of the
permeability tensor for the slice) and the solution fields relat-
ing to CSF/ISF clearance and accumulation. Observing
Table 3. Convergence plots as element number increases at different positions in the parenchymal domain. It should be noted that there are Dirichlet BCs
applied for certain variables, so the values do not change as the element number increases and their plots are not included here.
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for the control case; however, the solution field characteristics
are not similar. This is also true of the extent of CSF/ISF
accumulation and drainage. For the latter, the focal points
are the periventricular areas of high concavity on the anterior
and posterior horns of the lateral ventricles. Arrows indicate
the regions with peak drainage for the respective cases.
Figure 14d,e shows two overlapping solution fields relating
to the MCI patient, that of clearance and ICP.4. Discussion
In this work, the emphasis has been placed on being able to
associate some of the resulting outputs of the consolidated
framework outlined in §2 with a potential set-up to acquire
AD-specific biomarkers.
4.1. DArterial blood pressure, Dintracranial pressure
and flow rate
From figure 12 and the constituent peak values in table 4, it can
be observed that there is an increased blood flow rate from the
ICA (left and right) and VA during the period of high activity
when comparing the control andMCI case. The lower flow ratein the ICA and VA (that could be theoretically linked to a
reduced cardiac output) associated with the MCI case may
hint to a subtle underlying hypoperfusion that could develop
further in this patient. The results presented here compare
well with resting state values observed in the literature between
control and MCI cohorts [41,42]. It can be postulated that
chronically reducing cardiac output can be damaging, as
studies have shown that cerebral autoregulation does not
necessarily protect the brain under these circumstances [17].
This ultimately affects the maintenance of cerebral perfusion
pressure during ageing, which may subsequently promote
early glial activation, damage or destroy neurons in addition
to affecting necessary glucose distribution [17,43–45]. Various
cohort and population studies have shown an association
between hypertension and cognitive impairment [46], and it
is a well-known risk factor for developing dementia [1,47].
The results in table 5 indicate theDABPandDICP in both hemi-
spheres during both high and low activity. There was a
reduction in DABP of less than 1 mmHg for both hemispheres
in the control case, while the MCI case produced an asym-
metric reduction in DABP (greater than 1 mmHg). The
variation in DICP between activity states was not as pro-
nounced. This is anticipated, owing to the reduced flow rates
during low activity that are prescribed as arterial BCs to the
partitioned cortical surface shown in figure 12, and the
VPH-DARE@IT research platform (Lido data)
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Figure 6. The consolidated pipeline that incorporates the 3D MPET solver itself, with image- and non-image-based model personalization modules. (Online version
in colour.)
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impose themselves through the source terms in the CSF/ISF
compartment (equation (2.4)). An intrinsic requirement is
that the arteriole/capillary compartment acts as a mediator
to this process (owing to the directional constraints between
compartments (figure 1 and [48]).4.2. Clearance, perfusion, cerebrospinal fluid
accumulation and parenchymal tissue
displacement
Figure 13 shows that applying the aforementioned subject-
specific BCs to the arterial compartment influences the
structural MR
images
diffusion MR
images
VPH-DARE
research
platform
(image data)
inter-modality
image
segmentation
volumetric mesh
generation
ISO2Mesh
image
registration
NiftyReg
permeability
tensor field
interpolation
output
diffusion tensor
field estimation
TORTOISE
Figure 7. Workflow for the generation of subject-specific meshes and PTMs. The references for the tools used in this workflow can be found in [35] (TORTOISE),
[36] (NiftyReg) and [37] (ISO2Mesh). (Online version in colour.)
Figure 8. Region labels retained in segmentations. Distinct features incorporated into the model using the atlas-based propagation function, such as interthalamic
adhesion, fourth ventricle and separation of cerebral hemispheres, are clearly visible. (Online version in colour.)
LcH RcH LH RH
ITA
TV
CA
LV
FV
Figure 9. Brain geometry with distinct surface region labels, such as left cerebellar hemisphere (LcH), right cerebellar hemisphere (RcH), left cerebral hemisphere
(LH), right cerebral hemisphere (RH); and the ventricular system comprising lateral ventricles (LV), third ventricle (TV), interthalamic adhesion (ITA), fourth ventricle
(FV) and cerebral aqueduct (CA). (Online version in colour.)
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fluid compartments, in addition to the magnitude of dis-
placement of the parenchymal tissue (u). Global clearance is
marginally lower for the MCI case, while tissue displacement
and CSF/ISF accumulation (and drainage) are both increased.
The level of perfusion is similar (peak perfusion of 8 mm s21);
however, the solution field differs substantially in spatial
morphology. Ab homeostasis is governed by production and
clearance mechanisms [3]. Any subsequent imbalance in thishomeostasis may result in excessive accumulation of cerebral
Ab, which is a known characteristic of AD [15]. Evidence
suggests that impaired Ab clearance is apparent in both
early- and late-onset forms of AD [2]. Considering the inherent
need to critically understand the mechanism behind Ab clear-
ance, the current pipeline presented in this paper can be
considered as a possible test-bed for various hypotheses,
such as the influence of continuity between the ventricular
system, cisterns, para-vascular spaces and the subarachnoid
temporal
lobe
frontal
lobe
cerebellum
Figure 10. Tetrahedral mesh of the control subject generated from T1w-MR images. The figure on the top right-hand side shows a cross section of the volumetric
mesh, where the dark area represents the ventricular wall. The number of tetrahedral elements in this case is 2 772 075. (Online version in colour.)
DWIs DWIs pre-processing: DIFF-PREP
TORTOISE DIFF-CALC
principal eigenvalue
28
25
20
15
10
5
2
DTI estimation
Figure 11. (Top row) Workflow depicting results from pre-processing DWIs and estimating the DT field using TORTOISE [35]. (Bottom row) Principal eigenvalues in
the PTM of the control subject. (Online version in colour.)
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 on December 19, 2017http://rsfs.royalsocietypublishing.org/Downloaded from space (SAS) [49,50]. Soluble Ab can be transported via the
following clearance mechanisms [2]: across the blood–brain
barrier (BBB) and blood–CSF barriers, ISF bulk flow (facilitated
by astroglial aquaporin-4 channels) and CSF reabsorption into
the circulatory and lymphatic systems, and finally enzymatic
degradation and cellular uptake. In figure 13, the clearance
mechanism responsible for the results shown can be deemed
to possess an overlapping nature between BBB and ISF bulk
flow mediated uptake, because the arteriole/capillary and
CSF/ISF compartments are interlinked via the relevant
spatially varying source densities.
The results relating to CSF/ISF accumulation give an indi-
cation of the degree of swelling within the parenchymaltissue [28]. It is evident that periventricular swelling
dominates the solution field, while there are strategically
located pockets of extensive CSF/ISF extravasation (ze , 0).
Similar solution fields are obtained for the same cases
during low activity (sleep), and the results associated with
figure 13 are mentioned in §3 for reference. The tightly
coupled nature between the arterial BCs and the remaining
compartments of the MPET system is observed, considering
there is an overall global reduction in CSF/ISF clearance
and blood perfusion during the simulations involving the
flow profiles originating from low activity. Both u and ze
remain largely unaffected during this reduction in arterial
blood flow rate.
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Figure 12. (a) The four regions on the cortical surface that are used for the personalized BCs of arterial blood flow. (b) A snapshot of the waveforms of left and
right ICA and VA flow profiles corresponding to the period of high activity within a 24 h period for the control subject, (c) low activity for the control subject, (d ) for
high activity for the MCI subject and (e) for low activity for the MCI subject. (Online version in colour.)
Table 4. Peak ﬂow rate during high and low activity corresponding to the control and MCI cases.
ﬂow rate (ml min21)
high low
ICA_L ICA_R VA_L/R ICA_L ICA_R VA_L/R
control 540.6 493.1 129.2 324.3 294.5 77.3
MCI 449.9 460.2 113.8 308.1 313.7 77.7
Table 5. Range of ABP and ICP (max–min) for each hemisphere during high and low activity corresponding to the control and MCI cases.
DICP (mmHg) DABP (mmHg)
high low high low
L R L R L R L R
control 2.46 2.46 1.98 1.98 12.22 12.08 11.25 11.10
MCI 2.16 2.16 1.75 1.75 12.45 10.28 10.88 8.85
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the brain is accounted for via the subject-specific tissue per-
meability maps estimated from DT fields. These are encoded
within the tetrahedral element-based meshes used to conduct
the finite-element-based MPET simulations. Tuch et al. [51]
and Sarntinoranont et al. [52] presented evidence that both
the DT and permeability tensors share the same principal
eigenvector. Periventricular lucency [53] is represented by
positive ze values in the periventricular regions (qualitativeagreement exists in [28]). It is assumed to derive from ependy-
mal surface breakdown, which helps alleviate some of the
pressure in the cerebroventricular system by allowing for
some CSF extravasation (facilitated by aquaporin-4 [50,54]).
It can be seen from figure 14a–c that the underlying vari-
ations in directionality imposed by the permeability tensor
strongly influence the clearance pattern between the surface
of the ventricles and cortices. For the drainage of CSF/ISF
(ze, 0), the areas with peak values are highlighted in the
0.008
0.004
0
2.7
0
–2.3
0.027
0.013
0
0.0073
0.0050
0.0040
0.0020
0
clearance (m s–1) perfusion (m s–1) tissue displacement (m)
0.008
0.004
0
2.9
–0.9
–4.7
0.024
0.012
0
0.0082
0.0060
0.0040
0.0020
0
clearance (m s–1)
M
CI
co
n
tr
ol
perfusion (m s–1) tissue displacement (m) CSF/ISF accumulation
CSF/ISF accumulation
Figure 13. Midsagittal section depicting MPET results for CSF/ISF clearance, blood perfusion, parenchymal tissue displacement and accumulation of CSF/ISF.
All results are acquired during a period of high activity. (Online version in colour.)
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Figure 14. Axial slices through the cases corresponding to a male 66-year-old control and a male 78-year-old with MCI. (a) Principal eigenvalue of the permeability
tensor, (b) clearance and (c) CSF/ISF accumulation (ze). The two latter sets of results depict the influence of incorporating anisotropic permeability (which is influ-
enced by the local microstructure). Black arrows indicate the regions with peak drainage for the respective cases. (d ) An axial slice of the MCI case depicting the
clearance (CLR) of CSF/ISF (in the form of filtration velocity vectors) superimposed with the ICP solution field. (e) A coronal slice of the MCI case depicting clearance
(CLR) of CSF/ISF superimposed with the ICP solution field. (Online version in colour.)
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of high clearance, and support the CSF/ISF extravasation
theory in these locations (pore pressure is positive in these
areas [55]). The latter solution field is also influenced by the
strain alterations within the parenchymal tissue [55], and to a
lesser extent, the weighted proportion of ICP [28]. Further
refinement in this component of the pipeline may provide
further justification of the association between surrogate mar-
kers of brain dysfunction, such as in white matter lesions
with cognitive impairment and dementia [56]. From
figure 14d,e, it can be seen that the nature of the spatial distri-
bution of CSF/ISF clearance within the parenchyma is not
entirely dependent on the local underlying microstructure,
but also on the ICP (which lies within physiological levels[57]). Interrogating the differences in mechanical loads experi-
enced by the brain and the ensuing differences in fluid
clearance could identify new biomarkers related to vascular
risk factors of AD.4.3. Limitations and future work
In this extensive, yet preliminary study, only two non-smokers
from the Lido study cohort were analysed (execution of the
pipeline for the remaining cases is currently in progress). In
addition, the control subject lacked relevant information
related to their sleeping pattern (sleep-correlated changes of
cerebral blood flow, clearance of ISF etc. could not be made).
It would therefore be premature to expect the current results
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tant risk factors and cognitive impairment. The consolidated
pipeline presented in this work is able to integrate principles
of solid and fluid mechanics (as in [22,28]), and may aid in
better understanding hypotheses such as those identifying
the intricate mechanisms relating to pressure-driven atrophy
within the parenchymal tissue [58], in addition to considering
the role of repetitive and intensifying arterial pulsations (due to
the increased stiffness of the arterial tree during ageing) on the
underlying neuronal microstructure and glial function [16,58].
The link between modifiable LFs and cognitive decline is com-
plex. In the future, the influence of LFs that have an effect on the
vascular (cardiovascular and neurovascular) system physi-
ology will be investigated (such as smoking). Modelling an
LF by personalizing systemic variables, BCs and tissue consti-
tutive parameters can allow for an extended pipeline which
may account for the long-term response to hypothetical LF
patterns and timings.
Hypertension may itself result in hypoperfusion, via remo-
delling of small blood vessels and white matter alterations [1].
The MPET modelling framework is capable of incorporating
these features, provided that additional properties associated
with cognitive impairment are accounted for, such as the
expected variation in mechanical tissue properties and vascu-
lar compliance. Importantly, this will form part of a broader
study, which will involve the assessment of the consolidated
pipeline using the 103 Lido datasets.
The higher than usual ICP pressure gradients (typically,
only small fluctuations are observed in the literature [59])
are due to the blood and CSF/ISF compartments of the
MPET system being in tight communication via their intercom-
municating spatially varying source/sink terms. These terms
require further work in order to better accommodate physio-
logically representative microscale fluid transport. Recent
simulations of interstitial bulk flow within 3D electron micro-
scope reconstructions of hippocampal tissue [59] should also
be used as a means of conceptually extending the MPET
model (for instance, adding additional compartments in
order to simulate the CSF and ISF compartments separately)
in order to more accurately account for the glymphatic system
[60], and the understanding around its key constituents (inter-
stitial solute transport) [48]. Recent studies have shown that
solutes of varying sizes can be more easily transported through
the interstitium via diffusion as opposed to bulk flow, and
when combined with para-vascular advection, can provide a
credible alternative to the lymphatic drainage systems found
in other organs [59].The cortical SAS is neglected in the current study. Its
inclusion would allow for the relaxing of the assumed rigid
BC currently applied to the cortical surface. This would allow
for more accurate results relating to global parenchymal
tissue displacement (over the course of one or more cardiac
cycles), in addition to enhancing our understanding of intra-
cranial dynamics when the MPET model is extended to
include fluid–structure interaction.
Finally, the set of continuity equations for the MPET
system should take cross-porosity storage effects into account
[61–63]. Further limitations associated with the MPET system
have already been previously outlined [28].
5. Conclusion
This paper introduces a consolidated pipeline that intertwines
a 3Dmulti-poroelastic model of parenchymal tissue, an image-
based modelling pipeline and a detailed subject-specific BC
model. The implementation of the pipeline was described,
and is highlighted as the key component of this paper. Two
cases were simulated, one involving a 66-year-oldmale control
subject and one involving a 78-year-oldmaleMCI case. Both of
the cases were prescribed arterial BCs relating to a period of
high and low activity.
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